| Product NDC: | 63402-191 |
| Proprietary Name: | Lunesta |
| Non Proprietary Name: | ESZOPICLONE |
| Active Ingredient(s): | 2 mg/1 & nbsp; ESZOPICLONE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63402-191 |
| Labeler Name: | Sunovion |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021476 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050404 |
| Package NDC: | 63402-191-30 |
| Package Description: | 30 BLISTER PACK in 1 CARTON (63402-191-30) > 1 TABLET, COATED in 1 BLISTER PACK (63402-191-01) |
| NDC Code | 63402-191-30 |
| Proprietary Name | Lunesta |
| Package Description | 30 BLISTER PACK in 1 CARTON (63402-191-30) > 1 TABLET, COATED in 1 BLISTER PACK (63402-191-01) |
| Product NDC | 63402-191 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ESZOPICLONE |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20050404 |
| Marketing Category Name | NDA |
| Labeler Name | Sunovion |
| Substance Name | ESZOPICLONE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |